Splenic marginal zone lymphoma
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Splenic marginal zone lymphoma Classification and external resources | |
| ICD-O: | 9689/3 |
|---|---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [13] Phone:617-632-7753
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [14] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Synonyms
This disease was classified under the following names per older classification systems:[1]
| Classification system | Name |
|---|---|
| Rappaport | well-differentiated lymphocytic lymphoma |
| Lukes-Collins | small lymphocytic lymphoma |
| Working Formulation | small lymphocytic lymphoma |
| FAB | splenic lymphoma with circulating villous lymphocytes |
ICD-O Code
9689/3[1]
Definition
Splenic marginal zone lymphoma (SMZL) is a lymphoma comprised of B-cells that replace the normal architecture of the white pulp of the spleen. The neoplastic cells are both small lymphocytes and larger, transformed blasts, and they invade the mantle zone of splenic follicles and erode the marginal zone, ultimately invading the red pulp of the spleen. Frequently, the bone marrow and splenic hilar lymph nodes are involved along with the peripheral blood. The neoplastic cells circulating in the peripheral blood are termed villious lymphocytes due to their characteristic appearance.[1]
Epidemiology
Less than 1% of all lymphomas are splenic marginal zone lymphomas[2] and it is postulated that SMZL may represent a large fraction of unclasssifiable CD5- chronic lymphocytic leukemias.[1] The typical patient is over the age of 50, and gender preference has been described.[3]
Clinical Features
Etiology
The cell of origin is postulated to be a post-germinal center B-cell with an unknown degree of differentiation.[1]
Clinical Presentation
With splenic involvement a sine qua non for SMZL, splenomegaly is seen in almost all patients, commonly without lymphadenopathy.[1]
Laboratory Findings
Autoimmune thrombocytopenia and anemia sometimes seen in patients with SMZL. Circulating villous lymphocytes are sometimes observed in peripheral blood samples.[1] A monoclonal paraprotein is detected in a third of patients without hypergammaglobulinemia or hyperviscosity.[3][4]
Sites of Involvement
Aside from the uniform involvement of the spleen, the bone marrow is frequently positive in patients with SMZL. Nodal and extranodal involvement are rare.[1]
Morphology
Spleen
Reactive germinal centers in splenic white pulp are replaced by small neoplastic lymphocytes that efface the mantle zone and ultimately blend in with the marginal zone with occasional larger neoplastic cells that resemble blasts.[4][5] The red pulp is always involved, with both nodules of larger neoplastic cells and sheets of the small neoplastic lymphocytes. Other features that may been seen include sinus invasion, epithelial histocytes, and plasmacytic differentiation of neoplastic cells.
Splenic Hilar Lymph Nodes
Involved hilar lymph nodes adjacent to the spleen show an effaced architecture without preservation of the marginal zone seen in the spleen.[1]
Bone Marrow Biopsy
SMZL in bone marrow displays a nodular pattern with morphology similar to what is observed in the splenic hilar lymph nodes.[6]
Peripheral Blood
Circulating lymphoma cells are sometimes present in peripheral blood, and they occasionally show short villi at the poles of cells and plasmacytoid differentiation.[7]
Molecular Findings
Immunophenotype
| Antigen | Status |
|---|---|
| CD20 | Positive |
| CD79a | Positive |
| CD5 | Negative |
| CD10 | Negative |
| CD23 | Negative |
| CD43 | Negative |
| cyclin D1 | Negative |
The relevant markers that define the immunophenotype for SMZL are shown in the table to the right.[8][9] The lack of CD5 expression is helpful in the discrimination between SMZL and chronic lymphocytic leukemia/small lymphocytic lymphoma, and the lack of CD10 expression argues against follicular lymphoma. Mantle cell lymphoma is excluded due to the lack of CD5 and cyclin-D1 expression.[10]
Genetics
Clonal rearrangements of the immunoglobulin genes (heavy and light chains) are frequently seen.[11] The deletion 7q21-32 is seen in 40% of SMZL patients, and translocations of the CDK6 gene located at 7q21 have also been reported.[12]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 [1] Jaffe E.S., Harris N.L., Stein H., Vardiman J.W. (eds): World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of Haemopoietic and Lymphoid Tissues. IARC Press: Lyon 2001
- ↑ [2] Armitage JO, Weisenburger DD. "New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project." J Clin Oncol. 1998 Aug;16(8):2780-95. PMID: 9704731
- ↑ 3.0 3.1 [3] Berger F, Felman P, Thieblemont C, Pradier T, Baseggio L, Bryon PA, Salles G, Callet-Bauchu E, Coiffier B. "Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients." Blood. 2000 Mar 15;95(6):1950-6. PMID: 10706860
- ↑ 4.0 4.1 [4] Mollejo M, Menarguez J, Lloret E, Sanchez A, Campo E, Algara P, Cristobal E, Sanchez E, Piris MA. "Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases." Am J Surg Pathol. 1995 Oct;19(10):1146-57. PMID: 7573673
- ↑ [5] Jaffe ES, Costa J, Fauci AS, Cossman J, Tsokos M. "Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis." Am J Med. 1983 Nov;75(5):741-9. PMID: 6638043
- ↑ [6] Franco V, Florena AM, Campesi G. "Intrasinusoidal bone marrow infiltration: a possible hallmark of splenic lymphoma." Histopathology. 1996 Dec;29(6):571-5. PMID: 8971565
- ↑ [7] Melo JV, Hegde U, Parreira A, Thompson I, Lampert IA, Catovsky D. "Splenic B cell lymphoma with circulating villous lymphocytes: differential diagnosis of B cell leukaemias with large spleens." J Clin Pathol. 1987 Jun;40(6):642-51. PMID: 3497180
- ↑ [8] Isaacson PG, Matutes E, Burke M, Catovsky D. "The histopathology of splenic lymphoma with villous lymphocytes." Blood. 1994 Dec 1;84(11):3828-34. PMID: 7949139
- ↑ [9] Matutes E, Morilla R, Owusu-Ankomah K, Houlihan A, Catovsky D. "The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders." Blood. 1994 Mar 15;83(6):1558-62. PMID: 8123845
- ↑ [10] Savilo E, Campo E, Mollejo M, Pinyol M, Piris MA, Zukerberg LR, Yang WI, Koelliker DD, Nguyen PL, Harris NL. "Absence of cyclin D1 protein expression in splenic marginal zone lymphoma." Mod Pathol. 1998 Jul;11(7):601-6. PMID: 9688179
- ↑ [11] Dunn-Walters DK, Boursier L, Spencer J, Isaacson PG. "Analysis of immunoglobulin genes in splenic marginal zone lymphoma suggests ongoing mutation." Hum Pathol. 1998 Jun;29(6):585-93. PMID: 9635678
- ↑ [12] Corcoran MM, Mould SJ, Orchard JA, Ibbotson RE, Chapman RM, Boright AP, Platt C, Tsui LC, Scherer SW, Oscier DG. "Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations." Oncogene. 1999 Nov 4;18(46):6271-7. PMID: 10597225
WikiDoc Research Resources for Splenic marginal zone lymphoma | |
|---|---|
| Articles on Splenic marginal zone lymphoma | Most recent articles on Splenic marginal zone lymphoma • Most cited articles on Splenic marginal zone lymphoma • Review articles on Splenic marginal zone lymphoma • Articles on Splenic marginal zone lymphoma in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Splenic marginal zone lymphoma | Powerpoint slides on Splenic marginal zone lymphoma • Images of Splenic marginal zone lymphoma • Photos of Splenic marginal zone lymphoma • Podcasts & MP3s on Splenic marginal zone lymphoma • Videos on Splenic marginal zone lymphoma |
| Evidence Based Medicine Regarding Splenic marginal zone lymphoma | Cochrane Collaboration on Splenic marginal zone lymphoma • Bandolier on Splenic marginal zone lymphoma • TRIP on Splenic marginal zone lymphoma |
| Cost Effectiveness of Splenic marginal zone lymphoma | Cost Effectiveness of Splenic marginal zone lymphoma |
| Clinical Trials Involving Splenic marginal zone lymphoma | Ongoing Trials on Splenic marginal zone lymphoma at Clinical Trials.gov • Trial results on Splenic marginal zone lymphoma • Clinical Trials on Splenic marginal zone lymphoma at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Splenic marginal zone lymphoma | US National Guidelines Clearinghouse on Splenic marginal zone lymphoma • NICE Guidance on Splenic marginal zone lymphoma • NHS PRODIGY Guidance • FDA on Splenic marginal zone lymphoma • CDC on Splenic marginal zone lymphoma |
| Textbook Information on Splenic marginal zone lymphoma | Books and Textbook Information on Splenic marginal zone lymphoma |
| Pharmacology Resources on Splenic marginal zone lymphoma | Dosing of Splenic marginal zone lymphoma • Drug interactions with Splenic marginal zone lymphoma • Side effects of Splenic marginal zone lymphoma • Allergic reactions to Splenic marginal zone lymphoma • Overdose information on Splenic marginal zone lymphoma • Carcinogenicity information on Splenic marginal zone lymphoma • Splenic marginal zone lymphoma in pregnancy • Pharmacokinetics of Splenic marginal zone lymphoma • |
| Genetics, Pharmacogenomics, and Proteinomics of Splenic marginal zone lymphoma | Genetics of Splenic marginal zone lymphoma • Pharmacogenomics of Splenic marginal zone lymphoma • Proteomics of Splenic marginal zone lymphoma |
| Newstories on Splenic marginal zone lymphoma | Splenic marginal zone lymphoma in the news • Be alerted to news on Splenic marginal zone lymphoma • News trends on Splenic marginal zone lymphoma |
| Commentary on Splenic marginal zone lymphoma | Blogs on Splenic marginal zone lymphoma |
| Patient Resources on Splenic marginal zone lymphoma | Patient resources on Splenic marginal zone lymphoma • Discussion groups on Splenic marginal zone lymphoma • Patient Handouts on Splenic marginal zone lymphoma • Directions to Hospitals Treating Splenic marginal zone lymphoma • Risk calculators and risk factors for Splenic marginal zone lymphoma |
| Healthcare Provider Resources on Splenic marginal zone lymphoma | Symptoms of Splenic marginal zone lymphoma • Causes & Risk Factors for Splenic marginal zone lymphoma • Diagnostic studies for Splenic marginal zone lymphoma • Treatment of Splenic marginal zone lymphoma |
| Continuing Medical Education (CME) Programs on Splenic marginal zone lymphoma | CME Programs on Splenic marginal zone lymphoma |
| International Resources on Splenic marginal zone lymphoma | Splenic marginal zone lymphoma en Espanol • Splenic marginal zone lymphoma en Francais |
| Business Resources on Splenic marginal zone lymphoma | Splenic marginal zone lymphoma in the Marketplace • Patents on Splenic marginal zone lymphoma |
| Informatics Resources on Splenic marginal zone lymphoma | List of terms related to Splenic marginal zone lymphoma |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
